Theravance Biopharma Inc (NASDAQ:TBPH)

29.26
Delayed Data
As of Feb 16
 -0.35 / -1.18%
Today’s Change
22.90
Today|||52-Week Range
43.44
+4.91%
Year-to-Date

Today’s Trading

Previous close29.61
Today’s open29.48
Day’s range28.85 - 29.94
Volume86,699
Average volume (3 months)194,387
Market cap$1.6B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+20.22%
Earnings growth (this year)-14.32%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)+15.48%
P/E ratioNM
Price/Sales29.30
Price/Book4.41

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp-0.10-0.19%
ARRYArray Biopharma Inc-0.27-1.57%
RGENRepligen Corp-0.11-0.33%
CORTCorcept Therapeutics...+0.42+2.70%
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateMarch 13, 2018
EPS forecast (this quarter)-$1.17
Annual revenue (last year)$48.6M
Annual profit (last year)-$190.7M
Net profit margin-391.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Chief Financial Officer, Treasurer &
SVP
Renee D. Gala
Corporate headquarters
George Town, George Town

Forecasts